Argorna Pharmaceuticals Co., LTD
2 clinical trials · Sponsor
◉ Watch Argorna Pharmaceuticals Co., LTD
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster (NCT05897190) | Argorna Pharmaceuticals Co., LTD | 2022-05-16 |
| A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults (NCT05903118) | Argorna Pharmaceuticals Co., LTD | 2022-01-08 |
Track Argorna Pharmaceuticals Co., LTD automatically
Every clearance here is in the API, with alerts when new ones post.